News
Ireland is an “outlier” in not opposing European Union reforms of the pharmaceutical industry that would potentially damage ...
The future of aseptic small-batch manufacturing isn’t just about leading. Manufacturers who embrace automation, rethink ...
1d
Dealbreaker on MSNRoche Commits to $50B in U.S. Manufacturing and R&D Investments as Pharma Tariffs LoomRoche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, ...
8h
GlobalData on MSNThermo Fisher counters tariffs with $2bn investment into US manufacturingFollowing in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at ...
Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...
President Donald J. Trump’s imposition of steep “reciprocal tariffs,”—which he later paused for 90 days—to help bring ...
INDIANAPOLIS — Roche, a Swiss biotechnology company whose U.S. headquarters is in Indianapolis, has announced its intention ...
Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, development, and manufacturing.
Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is pleased to announce the upcoming publication of its patent for an innovative enzymatic method to ...
Roche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, making the pharmaceutical giant the latest company to unveil a capital ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results